Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005;22(1):47-59.
doi: 10.1007/s10585-005-2908-5.

Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior

Affiliations
Comparative Study

Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior

Alexander D Borowsky et al. Clin Exp Metastasis. 2005.

Abstract

Two cell lines, Met-1(fvb2) and DB-7(fvb2), with different metastatic potential, were derived from mammary carcinomas in FVB/N-Tg(MMTV-PyVmT) and FVB/N-Tg(MMTV-PyVmT ( Y315F/Y322F )) mice, transplanted into syngeneic FVB/N hosts and characterized. The lines maintain a stable morphological and biological phenotype after multiple rounds of in vitro culture and in vivo transplantation. The Met-1(fvb2) line derived from a FVB/N-Tg(MMTV-PyVmT) tumor exhibits invasive growth and 100% metastases when transplanted into the females FVB/N mammary fat pad. The DB-7(fvb2) line derived from the FVB/N-Tg(MMTV-PyVmT ( Y315F/Y322F )) with a "double base" modification at Y315F/Y322F exhibits more rapid growth when transplanted into the mammary fat pad, but a lower rate of metastasis (17%). The Met1(fvb2) cells show high activation of AKT, while DB-7(fvb2) cells show very low levels of AKT activation. The DNA content and gene expression levels of both cell lines are stable over multiple generations. Therefore, these two cell lines provide a stable, reproducible resource for the study of metastasis modulators, AKT molecular pathway interactions, and gene target and marker discovery.

PubMed Disclaimer

References

    1. Mol Cancer Res. 2004 Nov;2(11):632-42 - PubMed
    1. Mol Cell Biol. 1998 Apr;18(4):2344-59 - PubMed
    1. Genome Res. 2002 Jun;12 (6):969-75 - PubMed
    1. J Cell Physiol. 1998 Jul;176(1):206-15 - PubMed
    1. CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29 - PubMed

Publication types

Substances

LinkOut - more resources